Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Search results for

  • We unpack one of the biggest economic buzzwords of 2025: What is a "K-shaped' economy?
  • Nearly 20 years ago Clarence Aaron was sentenced to three life terms for his involvement in a drug deal. His request to have his sentence shortened was denied by the White House in 2008. Now a story by ProPublica's Dafna Linzer reports the Bush administration was not told key facts before deciding on it. Host Michel Martin speaks with Linzer.
  • Republicans have pounced on a comment by Newark, New Jersey mayor and Obama re-election surrogate Cory Booker. He called the Obama campaign's attacks on Mitt Romney's time at Bain Capital "nauseating." Host Michel Martin discusses the art of messaging with former presidential speechwriter Mary Kate Cary, and journalism professor Cynthia Tucker.
  • Trump can't serve more than twice because of the 22nd Amendment to the Constitution. The amendment's history is rooted in money, race and politics. Here's a look at how it came about.
  • Decades before Motown, Black Swan Records was the world's first major Black-owned record label. Radio Diaries brings us the story of Harry Pace and the mystery that kept him out of the history books.
  • The Serbian bested his Swiss rival 7-6, 6-7, 6-4, 6-3. It was the 40th time the two men had met on the court.
  • Columnist Mary Kate Cary, former Obama communications aide Corey Ealons, and NPR Political correspondent, Mara Liasson, discuss President Trump's attacks on the media and whether they serve a purpose.
  • The lessons of the final deal come down to this: Washington is very nearly broken. Next up? Finishing the work this agreement postponed.
  • At issue is whether the University of Texas, Austin discriminated against a white applicant when it did not offer her a spot. At Wednesday's argument, a court majority seemed poised to reverse or severely cut back previous decisions related to affirmative action programs in college admissions.
  • They were talented, idealistic risk-takers on the road to what they thought would be important medical discoveries. But when the funding for risk-takers dried up, these two academics called it quits.
1,633 of 8,203